Skip to content

Peripheral Vascular REactivity and Muscular Oxygenation in Diabetes Mellitus

Peripheral Vascular REactivity and Muscular Oxygenation in Diabetes Mellitus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04226820
Acronym
PREMOD
Enrollment
125
Registered
2020-01-13
Start date
2020-02-01
Completion date
2024-10-31
Last updated
2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Mitochondrial Diseases, Vascular Complications

Keywords

diabetes mellitus, muscular oxygenation, vascular function

Brief summary

Oxygen is required for an optimal muscle function. In patients with diabetes mellitus, hyperglycemia can cause vascular complications. The endothelium (inter layer of the blood vessels) can be damaged leading to a reduced oxygen flow towards the muscle cells. Besides, it is possible that mitochondrial dysfunction is occuring leading to reduced extraction of oxygen. Both conditions will lead to a reduced flow of oxygen towards the muscle and this can have impact on the production of energy necessary for optimal functioning. In this study, the investigators will examine the functionality of the blood vessels (1) and the uptake of oxygen into the muscles (2) in patients with diabetes mellitus type 1 and type 2 (with and without vascular complications) compared to healthy persons.

Detailed description

The investigators plan to recruit in total 125 participants who will be divided into 3 main groups: (I) diabetes mellitus type 1 (with (a) or without (b) vascular complications), (II) diabetes mellitus type 2 (with (a) or without (b) vascular complications), and (III) healthy persons. Diabetes mellitus will be defined by the guidelines of the American Diabetes Association (ADA). The examinations for this study consist of a blood pressure assessment, Flow Mediated Dilatation (FMD)-measurement, and a handgrip exercise test. The protocol will take approximately 2 hours. The investigator who performs the FMD-test followed a course and passed thorough evaluation. The blood pressure assessment will be continuously for 20 minutes to avoid large bias.

Interventions

OTHERexamination: blood pressure assessment

blood pressure measurement for 30 minutes, dominant side

OTHERexamination: Flow Mediated Dilatation (FMD)-test

Flow Mediated Dilatation (FMD)-test for measuring the endothelial functionality

OTHERexamination: handgrip exercise test with Near infrared spectroscopy (NIRS)-monitoring

participant does a maximal exercise test by a handgrip strength test with simultaneously monitoring of the muscular oxygenation

OTHERexamination: measurement of glucose by a finger prick

follow-up of blood sugar (glucose) during examinations by a finger prick

Sponsors

University Hospital, Ghent
CollaboratorOTHER
University Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Masking description

There is no masking because the participant knows his diagnosis. Besides, the investigator checks the blood sugar at different times during the examinations, so also the investigator is not blinded. In this study, blinding would have no additional value.

Intervention model description

Participants are divided into 3 groups based on their diagnosis: diabetes mellitus type 1, diabetes mellitus type 2, and healthy persons. Each participant (independent of group) will have the same examinations. There is no retesting of the same participant in other conditions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* men and women * age 18-85 years old * diabetes mellitus type 1 or type 2 (with or without vascular complications, healthy participants

Exclusion criteria

* other types of diabetes mellitus than type 1 or type 2 * alcohol abuse * active cancer * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Flow Mediated Dilatation (FMD)-test20 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)flow mediated dilatation test
Near-infrared spectroscopy during exercise30 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)analysis of changes in oxygenated blood during exercise
exercise test wilt hand held dynamometer30 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)analysis of strength and exercise capacity

Secondary

MeasureTime frameDescription
Blood pressure analysis20 minutes, at study-day (participants have to come only once, no follow-up, no re-testing)measurement of basal blood pressure (systolic and diastolic)

Countries

Belgium

Contacts

Primary ContactAnouk Tanghe, PhD
anouk.tanghe@ugent.be+32 09 332 36 27
Backup ContactPatrick Calders, Prof. dr.
patrick.calders@ugent.be+32 09 332 69 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026